Clinical trial
Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence…
NCT00338767 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00338767 |
|---|---|
| Title | Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy |
| Official title | Depression Treatment to Improve Antiretroviral Adherence |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Depression |
| Intervention type | Behavioral, Drug |
| Interventions | Directly Observed Therapy (DOT), Fluoxetine |
| Enrollment | 150 |
| Start date | Jan 1, 2001 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Nov 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: